Physician profile
Carlo Bellabarba
NPI 1174662431
$12,888.26
in general payments reported to CMS, 2019-2025
4 companies · $336 in 2025
The $336 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,239 · 2020: $1,500 · 2021: $2,075 · 2023: $213 · 2024: $2,525 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,154 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,000 · Food and Beverage: $920.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,154.33 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,000.00 |
| Food and Beverage | $919.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $10,814.19 | 2019-2024 | |
| Globus Medical, INC. | $1,329.19 | 2023-2024 | Creo Mis Stabilization System, Excelsiusgps Robotic Navigation System |
| Depuy Synthes Sales INC. | $719.88 | 2023-2025 | Velys, Teligen, Spine & Trauma 3d Navigation |
| Ricoh USA, INC | $25.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlo Bellabarba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.